EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (Synjardy) Nursing Considerations

What is the generic name?

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

What is the Trade Name for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE?

Synjardy

What are the Indications for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE?

• 1 INDICATIONS AND USAGE SYNJARDY is a combination of empagliflozin and metformin hydrochloride (HCl) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus . Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease [see Clinical Studies (14) ] . SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. ( 1 ) Limitation of Use : Not recommended in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients. ( 1 ) Limitation of Use SYNJARDY is not recommended in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients [see Warnings and Precautions (5.2) ] .

References: https://open.fda.gov/